Investigation and mutiple pending lawsuit against Bristol-Myers Squibb and Schering Corporation, the makers of Tequin, alleging that the antibiotic may significantly increase a patient's risk of developing diabetes or another blood-sugar disorder.
Tequin - from the fluoroquinolone spectrum of antibiotics - is commonly prescribed for sinus, lung, urinary tract infections, and other conditions.
Safety concerns regarding Tequin began to surface in 2001, two years after the drug was approved by the Food and Drug Administration, when medical literature began suggesting a link between Tequin and dysglycemia among diabetics and non-diabetics, the suit alleges. A Canadian study cited in the March 2006 issue of the New England Journal of Medicine found that Tequin users had 17 times greater risk of developing serious diabetes and four times greater risk of being hospitalized with low blood sugar complications than patients using other antibiotics. Some of the symptoms caused by abnormally low or high blood sugar include nervousness, dizziness, shortness of breath, nausea, vomiting, anxiety, passing out, and confusion. Blood sugar disorders have also been shown to cause low blood pressure that may result in heart attack or renal failure.
In March of 2006 Bristol-Meyers Squibb announced to its shareholders that it would stop making and selling Tequin.
Do not change medications without first consulting your doctor.
Name (Stock Symbol)
Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company is a large pharmaceutical company that also manufactures and develops medical devices.
Schering-Plough Corporation (SGP)
Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.